Fundz

Real-time funding, M&A, exec moves & hiring — the signals that move deals

More real-time opportunities that match your ICP — every funding, M&A, and exec move the moment it breaks, with the verified contacts to reach out first.

The funding market, moving in real timeBook a DemoStart with Pro — $79/mo
Loading live signals…

Funding, M&A, exec moves & hiring — every signal Fundz sees, the moment it happens. See who’s in your market, who to reach, and why now.

Back to SEC Filings
Material AgreementItem 1.01 · 8-KLOW RiskPositive

ALTO NEUROSCIENCE, INC.

www.altoneuroscience.com
Filed: Mar 16, 2026Los AltosCIK: 0001999480Health Care
Watch CompanyView on SEC.gov

AI Executive Summary

AI-powered analysis of 8-K filing content

Alto Neuroscience completed a $58 million private placement on March 16, 2026, issuing 2.9 million shares at $20 per share plus pre-funded warrants for 3.1 million additional shares. This capital raise demonstrates strong institutional investor confidence and significantly strengthens the company's financial position to fund development and research initiatives.

Key Takeaways

Alto Neuroscience raised $58 million through a private placement of common stock and pre-funded warrants

2.9 million shares issued at $20.00 per share with additional pre-funded warrants for 3.1 million shares

2 more takeaways

Filing Overview

Form Type8-K
Filing DateMar 16, 2026
Item1.01
CategoryMaterial Agreement
CIK0001999480
Accession #001-41944
Risk LevelLOW
SentimentPositive
Signalopportunity
Topics
stock offeringmaterial agreement

What This Means

The company entered into a significant agreement that could materially affect its business. This often signals new partnerships, licensing deals, or major contracts.
View Full Filing on SEC.govBrowse More Filings